Share capital

Capital increase of 80,553 shares (equivalent to approximately 0.23% of the existing shares) in Orphazyme A/S as a result of an issue of bonus shares to KUMCRI and directed issuance of new shares

Retrieved on: 
Thursday, February 25, 2021
Financial markets, Corporate law, Corporate finance, Finance, Financial capital, Stock market, Dividends, Equity securities, Share capital, Par value, Bonus share, Share

The capital increase was decided pursuant to the Board of Directors authorization laid down in Article 3.2 and 3.3 of the Articles of Association.

Key Points: 
  • The capital increase was decided pursuant to the Board of Directors authorization laid down in Article 3.2 and 3.3 of the Articles of Association.
  • Accordingly, the Companys share capital will be increased by nominally DKK 22,553 by way of an issue of bonus shares at par value by transfer of DKK 22,553 from the Companys distributable reserves.
  • Thus, the Company will issue 58,000 new shares each with a nominal value of DKK 1, and the share capital will be increased by nominally DKK 58,000.
  • Following the share capital increase, the total nominal share capital will be DKK 34,948,387, divided into 34,948,387 shares each with a nominal value of DKK 1.

Pharnext Announces Financing of €11 Million Through a Capital Raise Subscribed by Existing Shareholders and a Convertible Bonds Issued to European Investors

Retrieved on: 
Thursday, February 4, 2021
Finance, Financial economics, Corporate finance, Financial capital, Convertible bond, Share capital, Convertible security, Bond, Stock market

"We are pleased to announce this capital raise which demonstrates the strong continued support of our existing shareholders", said David Horn Solomon, Chief Executive Officer.

Key Points: 
  • "We are pleased to announce this capital raise which demonstrates the strong continued support of our existing shareholders", said David Horn Solomon, Chief Executive Officer.
  • "This funding will extend our cash runway to advance PXT3003 into the pivotal phase III trial in Charcot-Marie-Tooth disease Type 1A".
  • New shares resulting from the conversion of Convertible Bonds will be fully fungible with existing ordinary shares and will enjoy the same rights.
  • Following completion of the Capital Raise, they will own 14.45% and 24.14% respectively of the share capital of the Company.

HOPIUM Announces The Success Of Its Capital Increase By Private Placement For An Amount Of 5 Million Euros

Retrieved on: 
Thursday, February 4, 2021
Financial markets, Finance, Financial economics, Stock market, Equity securities, Financial capital, Corporate finance, Par value, Valuation, Share capital, Share, Euro

The operation resulted in the issuance of 584,795 new shares with a unit par value of 0.01, i.e.

Key Points: 
  • The operation resulted in the issuance of 584,795 new shares with a unit par value of 0.01, i.e.
  • 4.998% of the Company's current share capital, at a price of 8.55 per share (issue premium included), for a total amount of 5 million euros (i.e.
  • Following the Operation, the Company's share capital now consists of 12,284,795 shares with a par value of 0.01 euro each.
  • To the best of the Company's knowledge, the shareholding breakdown after completion of the transaction is as follows:

HOPIUM Announces The Success Of Its Capital Increase By Private Placement For An Amount Of 5 Million Euros

Retrieved on: 
Thursday, February 4, 2021
Financial markets, Finance, Financial economics, Stock market, Equity securities, Financial capital, Corporate finance, Par value, Valuation, Share capital, Share, Euro

The operation resulted in the issuance of 584,795 new shares with a unit par value of 0.01, i.e.

Key Points: 
  • The operation resulted in the issuance of 584,795 new shares with a unit par value of 0.01, i.e.
  • 4.998% of the Company's current share capital, at a price of 8.55 per share (issue premium included), for a total amount of 5 million euros (i.e.
  • Following the Operation, the Company's share capital now consists of 12,284,795 shares with a par value of 0.01 euro each.
  • To the best of the Company's knowledge, the shareholding breakdown after completion of the transaction is as follows:

Travis Perkins: Total Voting Rights

Retrieved on: 
Wednesday, February 3, 2021
Financial markets, Corporate finance, Financial economics, Finance, Stock market, Equity securities, Corporate law, Issued shares, Common stock, Share capital, Share, Treasury stock

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • In conformity with DTR5.6.1R, the Company notifies the market of the following:
    As at the date of this announcement, the Company's issued share capital consists of 252,143,923 ordinary shares with a nominal value of 10 pence each ("Ordinary Shares"), with voting rights.
  • The Company does not hold any Ordinary Shares in Treasury.
  • Therefore, the total number of Ordinary Shares with voting rights is 252,143,923.

Capital increase of 170,131 shares in Orphazyme A/S as a result of vesting and exercise of Matching Shares

Retrieved on: 
Monday, February 1, 2021
Corporate law, Financial capital, Share capital, Dickkopf

A total of 170,131 shares of nominally DKK 1 each have been issued by the Company at a subscription price per Matching Share of DKK 1.

Key Points: 
  • A total of 170,131 shares of nominally DKK 1 each have been issued by the Company at a subscription price per Matching Share of DKK 1.
  • Following the share capital increase, the total nominal share capital will be DKK 34,867,834, divided into 34,867,834 shares each with a nominal value of DKK 1.
  • Each share carries one vote at Orphazyme's general meetings and accordingly the total number of voting rights of the company are 34,867,834.
  • Orphazyme is a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases.

GRAND CITY PROPERTIES S.A. ANNOUNCES SHARE BUYBACK

Retrieved on: 
Thursday, January 28, 2021
Stock market, Buyback, Share repurchase, Share capital, Financial economics, Finance, Corporations, Corporate finance, Shareholders

The share buyback utilizes the authorization provided by the General Annual Meeting (AGM) held on June 24 2020, by which the Board of Directors may acquire up to 20% of the aggregate nominal amount of the issued share capital.

Key Points: 
  • The share buyback utilizes the authorization provided by the General Annual Meeting (AGM) held on June 24 2020, by which the Board of Directors may acquire up to 20% of the aggregate nominal amount of the issued share capital.
  • The share buyback has been launched on the back of GCP's strong operational performance and increasing EPRA NAV per share, while the share is being traded at a discount to EPRA NAV.
  • Therefore, the Company has decided to use the opportunity to create further long-term shareholder value and accretive per share growth through the buyback of its shares at discount.
  • The share buyback is supported by the robust equity base and the high liquidity of the Company and is in-line with GCP's conservative financial policy.

DGAP-News: GRAND CITY PROPERTIES S.A. ANNOUNCES SHARE BUYBACK

Retrieved on: 
Thursday, January 28, 2021
Stock market, Buyback, Share repurchase, Share capital, Financial economics, Finance, Corporations, Corporate finance, Shareholders

The share buyback utilizes the authorization provided by the General Annual Meeting (AGM) held on June 24 2020, by which the Board of Directors may acquire up to 20% of the aggregate nominal amount of the issued share capital.

Key Points: 
  • The share buyback utilizes the authorization provided by the General Annual Meeting (AGM) held on June 24 2020, by which the Board of Directors may acquire up to 20% of the aggregate nominal amount of the issued share capital.
  • The share buyback has been launched on the back of GCP's strong operational performance and increasing EPRA NAV per share, while the share is being traded at a discount to EPRA NAV.
  • Therefore, the Company has decided to use the opportunity to create further long-term shareholder value and accretive per share growth through the buyback of its shares at discount.
  • The share buyback is supported by the robust equity base and the high liquidity of the Company and is in-line with GCP's conservative financial policy.

Next Private: Transfer of Altice Europe Shares

Retrieved on: 
Wednesday, January 20, 2021
Mobile, Wireless, Technology, Finance, Banking, Telecommunications, Professional services, Internet, Data management, Consumer electronics, Other Professional Services, Stock market, Corporate law, Altice, Financial economics, Finance, Companies, Patrick Drahi, Share capital, Issued shares, Share

("Next Alt"), pursuant to the provisions of Section 13, paragraphs 1 and 2 of the Dutch Decree on Public Takeover Bids (Besluit openbare biedingen Wft), in connection with the public offer by Next Private for all issued and outstanding common shares A and common shares B in the capital of Altice Europe N.V. ("Altice Europe").

Key Points: 
  • ("Next Alt"), pursuant to the provisions of Section 13, paragraphs 1 and 2 of the Dutch Decree on Public Takeover Bids (Besluit openbare biedingen Wft), in connection with the public offer by Next Private for all issued and outstanding common shares A and common shares B in the capital of Altice Europe N.V. ("Altice Europe").
  • distributed 150,700,000 common shares A in the capital of Altice Europe (the "Shares") to its sole shareholder Next Alt and Next Alt subsequently contributed the Shares by way of share premium contribution to its wholly-owned subsidiary Next Private.
  • Next Private holds 340,226,447 common shares A and 167,660,043 common shares B in the capital of Altice Europe, representing approximately 76.21% of Altice Europe's issued share capital; and
    Next Alt holds 81,238,465 common shares A in the capital of Altice Europe, representing approximately 1.37% of Altice Europe's issued share capital, of which 35,000,000 are subject to a right of use (as described in sections 6.9 and 6.10(c) of the Offer Memorandum).
  • Next Private and its sole shareholder Next Alt are owned and controlled by Mr. Patrick Drahi, the founder and majority shareholder of Altice Europe.

Total Voting Rights and Share Capital

Retrieved on: 
Monday, January 4, 2021
Financial markets, Financial economics, Corporate finance, Finance, Stock market, Equity securities, Corporate law, Treasury stock, Issued shares, Share capital, Share, Common stock

As at 4 January 2021, the issued share capital of DMGT comprised 210,798,306 A Ordinary Non-Voting shares (excluding treasury shares) par value 12.5 pence per share; and 19,890,364 Ordinary shares par value 12.5 pence per share with one vote per share.

Key Points: 
  • As at 4 January 2021, the issued share capital of DMGT comprised 210,798,306 A Ordinary Non-Voting shares (excluding treasury shares) par value 12.5 pence per share; and 19,890,364 Ordinary shares par value 12.5 pence per share with one vote per share.
  • The number of A Ordinary Non-Voting shares which are held in treasury is 4,115,021.
  • Treasury shares are not taken into consideration in relation to the payment of dividends and voting at shareholder meetings.
  • The total number of voting rights in DMGT is 19,890,364.